Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study. (Q44614482)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 March 2009
edit
Language Label Description Also known as
English
Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study.
scientific article published on 9 March 2009

    Statements

    Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study (English)
    Spanish Group for Stem Cell Transplantation (Grupo Español de Trasplante Hemopoyético y Terapia Celular)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit